|
Expression levels of genes of NKG2C+ NK cells after in vitro treatment |
166.87 |
|
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] |
49.66 |
|
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies |
49.66 |
|
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO |
46.56 |
|
Total RNA-seq in ALL-SIL upon JQ1 inhibition |
43.07 |
|
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate |
36.28 |
|
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing |
35.19 |
|
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) |
35.19 |
|
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions |
33.79 |
|
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation |
30.76 |
|
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) |
28.95 |
|
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) |
28.59 |
|
CircRNAome diversity in human mature B-cells, T-cells and monocytes |
27.8 |
|
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia |
27.6 |
|
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] |
27.6 |
|
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 |
26.04 |
|
SRSF2 mutations impair hematopoiesis and alter exon recognition |
25.6 |
|
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens |
23.07 |
|
Landscape of H3K4me3 in human CD19 cells |
22.43 |
|
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance |
22.24 |
|
The role of FAM46C in myeloma cells [sequencing] |
21.68 |
|
The role of FAM46C in myeloma cells |
21.68 |
|
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology |
21.32 |
|
MYCi975 regulates MYC target genes |
20.93 |
|
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 |
20.7 |
|
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers |
20.58 |
|
snRNAs as regulators of alternative splicing |
20.37 |
|
Hijacking of stress response machinery by oncogenes in acute leukaemia |
20.33 |
|
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] |
20.33 |
|
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway |
20.15 |
|
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] |
19.97 |
|
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL |
19.97 |
|
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs |
18.76 |
|
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans |
18.07 |
|
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans |
18.07 |
|
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth |
17.87 |
|
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells |
17.26 |
|
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells |
17.22 |
|
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity |
16.9 |
|
RNAseq of T-ALL upon long non coding rna purturbation |
16.69 |
|
Intrahepatic MAIT cell gene expression revealed by RNA-seq |
16.26 |
|
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts |
15.75 |
|
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity |
15.52 |
|
Genome-wide analysis of ferroptosis related genes in liver cancer cells. |
15.37 |
|
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) |
14.97 |
|
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors |
14.97 |
|
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming |
14.85 |
|
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells |
14.76 |
|
Glioblastoma stem cells infected by ZIKA virus |
14.53 |
|
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples |
14.49 |
|
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples |
14.49 |
|
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B |
14.3 |
|
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells |
13.86 |
|
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs |
13.29 |
|
Primary Human B-cell Temporal Response to CD40L Stimulation |
13.08 |
|
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells |
12.94 |
|
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity |
12.46 |
|
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA |
12.45 |
|
Transcriptional changes in lymphoma cells induced by LSD1 depletion |
12.34 |
|
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis |
12.34 |
|
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies |
12.2 |
|
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. |
11.84 |
|
MYC dependent mRNA translation shapes gene expression and cell biology |
11.44 |
|
Human T-cell lymphoblastic lymphoma samples and control thymuses |
11.37 |
|
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses |
11.37 |
|
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma |
11.09 |
|
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) |
11.09 |
|
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) |
10.69 |
|
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER |
10.49 |
|
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 |
10.43 |
|
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling |
10.2 |
|
Transcriptomic analysis of LSD1 |
10.02 |
|
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 |
9.81 |
|
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma |
9.63 |
|
Polarized B -cell functions |
9.42 |
|
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 |
9.2 |
|
RNA-seq analyisis of PUM2 knockout cells |
9.11 |
|
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] |
9.09 |
|
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator |
9.09 |
|
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression |
9.08 |
|
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia |
9.0 |
|
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma |
8.93 |
|
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer |
8.89 |
|
Seletive inhibition of CDK9 in DLBCL cell lines |
8.53 |
|
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] |
8.48 |
|
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells |
8.48 |
|
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells |
8.45 |
|
Ro60-knockout cells |
8.43 |
|
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) |
8.42 |
|
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition |
8.42 |
|
RNA-sequencing of the GSI treatment of the CUTLL1 cell line |
7.95 |
|
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa |
7.85 |
|
Human Treg IL-12 stimulation |
7.7 |
|
Transcriptome of activated human and mouse MAIT cells |
7.65 |
|
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria |
7.61 |
|
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] |
7.58 |
|
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas |
7.44 |
|
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease |
7.42 |
|
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E |
7.38 |
|
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] |
7.33 |
|
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia |
7.29 |
|
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors |
7.24 |
|
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression |
7.17 |
|
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations |
7.15 |
|
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection |
7.1 |
|
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] |
7.07 |
|
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis |
7.04 |
|
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] |
7.04 |
|
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation |
7.0 |
|
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis |
6.93 |
|
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] |
6.9 |
|
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro |
6.82 |
|
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues |
6.82 |
|
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia |
6.72 |
|
Microprocessor mediates transcription termination in long noncoding microRNA genes |
6.69 |
|
Characterisation of the myeloid differentiation process of human hematopoietic stem cells |
6.68 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes |
6.64 |
|
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation |
6.6 |
|
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] |
6.6 |
|
The pause-initiation limit restricts transcription activation in human cells |
6.6 |
|
RNA sequencing with KSHV infection and enrichment for circular RNAs |
6.51 |
|
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 |
6.5 |
|
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 |
6.41 |
|
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) |
6.31 |
|
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma |
6.31 |
|
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation |
6.26 |
|
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma |
6.25 |
|
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation |
6.13 |
|
Clinker: visualizing fusion genes detected in RNA-seq data |
6.11 |
|
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo |
6.11 |
|
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay |
6.07 |
|
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells |
6.05 |
|
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) |
6.02 |
|
Gene expression analysis of the impact of TDP-43 knockout in human cells. |
5.99 |
|
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. |
5.98 |
|
Cajal bodies are linked to genome conformation |
5.96 |
|
Cajal bodies are linked to genome conformation [RNA-Seq] |
5.96 |
|
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity |
5.82 |
|
UBC9 knockdown in bladder cancer T24 cell lines |
5.73 |
|
MeRIP-seq for heat shock in B-cell lymphoma cells |
5.69 |
|
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells |
5.69 |
|
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes |
5.67 |
|
Trans-differentiation of human adult peripheral blood T cells into neurons |
5.63 |
|
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction |
5.51 |
|
Bone marrow derived human B cells [normal proB] |
5.48 |
|
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) |
5.47 |
|
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice |
5.45 |
|
Crizotinib v. DMSO in SW480 cells |
5.39 |
|
MOF acetyl transferase regulates transcription and respiration in mitochondria |
5.36 |
|
Accurate annotation of human protein-coding small open reading frames |
5.3 |
|
Identification of global regulators of T-helper cell lineage specification |
5.28 |
|
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) |
5.28 |
|
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors |
5.24 |
|
Widespread intronic polyadenylation diversifies immune cell transcriptomes |
5.22 |
|
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. |
5.19 |
|
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma |
5.11 |
|
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors |
5.11 |
|
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants |
5.09 |
|
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma |
5.03 |
|
Hepatosplenic T cell lymphoma |
5.03 |
|
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) |
5.02 |
|
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription |
5.01 |
|
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients |
4.97 |
|
Nuclear Parkin Regulates Transcriptional Response during Hypoxia |
4.89 |
|
A single cell reference map for human blood and tissue T cell activation |
4.89 |
|
Widespread regulated alternative splicing of single codons accelerates proteome evolution |
4.86 |
|
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness |
4.84 |
|
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer |
4.77 |
|
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells |
4.76 |
|
Alu RNA modulates the expression of cell cycle genes in human fibroblasts |
4.75 |
|
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis |
4.74 |
|
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition |
4.73 |
|
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) |
4.68 |
|
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma |
4.68 |
|
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection |
4.65 |
|
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics |
4.62 |
|
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) |
4.62 |
|
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection |
4.55 |
|
ChIP-seq and RNA-seq from human lymphoma cell lines |
4.49 |
|
RNA-seq data from human lymphoma cell lines |
4.49 |
|
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 |
4.47 |
|
RNA-seq of resting and activated CD4+ T cells +-JQ1 |
4.44 |
|
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates |
4.39 |
|
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals |
4.37 |
|
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells |
4.36 |
|
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node |
4.35 |
|
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma |
4.25 |
|
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) |
4.21 |
|
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor |
4.15 |
|
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat |
4.13 |
|
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation |
4.13 |
|
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor |
4.09 |
|
|
4.09 |
|
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment |
4.01 |
|
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans |
4.0 |
|
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival |
3.98 |
|
Transcriptome analysis in Neobractatin treated cells |
3.95 |
|
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells |
3.92 |
|
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions |
3.91 |
|
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] |
3.91 |
|
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] |
3.9 |
|
Dynamic 3D chromosomal landscapes in acute leukemia |
3.9 |
|
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 |
3.84 |
|
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control |
3.81 |
|
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death |
3.8 |
|
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] |
3.77 |
|
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. |
3.77 |
|
Epigenetic reprogramming of melanoma cells by vitamin C treatment |
3.74 |
|
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis |
3.65 |
|
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma |
3.65 |
|
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures |
3.65 |
|
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] |
3.65 |
|
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin |
3.65 |
|
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO |
3.58 |
|
Genes altered in expression by Cisplatin treatment in lung cancer cell lines |
3.54 |
|
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution |
3.54 |
|
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 |
3.52 |
|
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) |
3.51 |
|
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] |
3.5 |
|
Genome wide miR-191 target profile determined by RIP and gene expression profiling |
3.5 |
|
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways |
3.5 |
|
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability |
3.46 |
|
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) |
3.46 |
|
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. |
3.43 |
|
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control |
3.42 |
|
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M |
3.4 |
|
Transcriptomes in healthy and CHB fetal hearts |
3.39 |
|
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing |
3.39 |
|
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer |
3.39 |
|
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells |
3.37 |
|
Gene expression changes due to PARP knockdown in human cells |
3.34 |
|
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses |
3.32 |
|
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation |
3.26 |
|
The landscape of alternative splicing in aggressive prostate cancers |
3.26 |
|
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor |
3.25 |
|
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation |
3.25 |
|
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent |
3.24 |
|
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) |
3.24 |
|
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export |
3.23 |
|
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells |
3.21 |
|
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO |
3.13 |
|
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) |
3.13 |
|
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes |
3.13 |
|
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation |
3.09 |
|
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma |
3.06 |
|
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated |
3.06 |
|
Functional significance of the HIV-1 Tat signature amino acid residues |
3.05 |
|
Dtx3L and Androgen Signaling in Prostate Cancer |
3.0 |
|
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] |
2.94 |
|
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer |
2.94 |
|
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] |
2.94 |
|
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer |
2.94 |
|
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. |
2.93 |
|
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth |
2.93 |
|
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid |
2.92 |
|
Genes significantly down or Up-regulated upon RNF219 knockdown |
2.91 |
|
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. |
2.9 |
|
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing |
2.9 |
|
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies |
2.9 |
|
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis |
2.9 |
|
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] |
2.89 |
|
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer |
2.89 |
|
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells |
2.87 |
|
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs |
2.85 |
|
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates |
2.84 |
|
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival |
2.82 |
|
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG |
2.8 |
|
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] |
2.8 |
|
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells |
2.8 |
|
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 |
2.79 |
|
Genome wide expression change by RNF168 knocking down in MCF-7 cells |
2.79 |
|
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase |
2.77 |
|
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells |
2.76 |
|
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals |
2.68 |
|
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line |
2.65 |
|
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] |
2.65 |
|
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) |
2.65 |
|
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia |
2.64 |
|
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export |
2.61 |
|
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. |
2.61 |
|
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] |
2.6 |
|
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression |
2.59 |
|
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins |
2.51 |
|
The evolution of N6-methyladenosine in primates |
2.46 |
|
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer |
2.46 |
|
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU |
2.44 |
|
FOXP3 protects conventional human T cells from premature restimulation-induced cell death |
2.43 |
|
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients |
2.42 |
|
Epigenomic conservation of transposable element silencing [RNA-seq] |
2.33 |
|
Epigenomic conservation of transposable element silencing |
2.33 |
|
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification |
2.33 |
|
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown |
2.32 |
|
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload |
2.32 |
|
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway |
2.31 |
|
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells |
2.3 |
|
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling |
2.29 |
|
Transcriptome of human white and brown adipose tissue biopsies |
2.28 |
|
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis |
2.23 |
|
Characterization of human ILC2 subsets |
2.21 |
|
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer |
2.16 |
|
Landscape and variation of RNA secondary structure across the human transcriptome |
2.16 |
|
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib |
2.14 |
|
Intron retention induced by microsatellite expansions as a disease biomarker. |
2.13 |
|
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments |
2.13 |
|
Dysregulated immune system networks in war veterans with PTSD |
2.1 |
|
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells |
2.09 |
|
hnRNP C is a key regulator of protein synthesis in mitosis |
2.09 |
|
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes |
2.07 |
|
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 |
2.03 |
|
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 |
2.02 |
|
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) |
2.01 |
|
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. |
2.01 |
|
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity |
2.01 |
|
Be1 and Be2 B cells are transcriptionally distinct |
1.98 |
|
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling |
1.97 |
|
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] |
1.94 |
|
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability |
1.94 |
|
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation |
1.94 |
|
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 |
1.91 |
|
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II |
1.9 |
|
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells |
1.9 |
|
A Unique Epigenomic Landscape Defines Human Erythropoiesis |
1.9 |
|
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) |
1.9 |
|
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development |
1.89 |
|
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] |
1.89 |
|
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 |
1.88 |
|
ADAR1-editing of cellular and measles virus-derived duplex RNA |
1.85 |
|
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes |
1.85 |
|
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 |
1.85 |
|
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation |
1.83 |
|
Primate transcript and protein expression levels evolve under compensatory selection pressures |
1.81 |
|
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 |
1.81 |
|
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization |
1.78 |
|
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma |
1.73 |
|
Leucegene: ALL sequencing |
1.73 |
|
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls |
1.72 |
|
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. |
1.69 |
|
Statins modulate endothelial transcriptional profile by inhibiting EZH2 |
1.69 |
|
hnRNP L protects mRNAs from nonsense-mediated mRNA decay |
1.68 |
|
Expression and functions of long noncoding RNAs during human T helper cell differentiation |
1.67 |
|
A novel target of EZH1/2 for treatment of mantle cell lymphoma |
1.67 |
|
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. |
1.66 |
|
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) |
1.64 |
|
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression |
1.63 |
|
RNA-Seq and expression data from human adipose tissue |
1.61 |
|
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases |
1.61 |
|
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) |
1.6 |
|
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers |
1.6 |
|
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains |
1.6 |
|
Transcriptional effect of ETV1 knockdown in melanoma cells |
1.58 |
|
quanTIseq: quantifying immune contexture of human tumors |
1.55 |
|
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs |
1.53 |
|
The effect of Abl kinases on non-small cell carcinoma global transcriptome |
1.53 |
|
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation |
1.52 |
|
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] |
1.46 |
|
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown |
1.46 |
|
Expression patterns in chronic thromboembolic pulmonary hypertension |
1.45 |
|
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 |
1.44 |
|
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection |
1.42 |
|
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease |
1.41 |
|
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells |
1.41 |
|
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance |
1.41 |
|
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing |
1.36 |
|
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats |
1.35 |
|
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming |
1.34 |
|
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq |
1.34 |
|
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis |
1.32 |
|
RNA sequencing of T-ALL (COG study) |
1.32 |
|
Analyses of T-ALL (COG study) |
1.32 |
|
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines |
1.31 |
|
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] |
1.3 |
|
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells |
1.28 |
|
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] |
1.27 |
|
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters |
1.27 |
|
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq |
1.27 |
|
Loss of CREBBP results in gene expression repression in lymphoma cells |
1.26 |
|
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells |
1.26 |
|
Characterization of parental and rociletinib-resistant derived H1975 cell lines |
1.25 |
|
SOX11 knockdown in B-ALL cell lines |
1.25 |
|
MHC Transcriptomic landscape at haplotype-specific resolution |
1.23 |
|
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) |
1.22 |
|
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 |
1.22 |
|
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones |
1.22 |
|
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins |
1.2 |
|
Non-coding regions are the main source of tumor-specific antigens |
1.2 |
|
Non-coding regions are the main source of tumor-specific antigens [human] |
1.2 |
|
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors |
1.16 |
|
Total RNA-seq in ALL-SIL upon TLX1 knockdown |
1.15 |
|
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells |
1.15 |
|
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) |
1.15 |
|
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma |
1.14 |
|
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site |
1.11 |
|
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia |
1.1 |
|
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile |
1.09 |
|
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues |
1.07 |
|
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells |
1.06 |
|
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells |
1.04 |
|
Multi-omic measurements of heterogeneity in HeLa cells across laboratories |
1.04 |
|
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients |
1.04 |
|
Defective structural RNA processing in relapsing-remitting multiple sclerosis |
1.04 |
|
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 |
1.02 |
|
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells |
1.02 |
|
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] |
1.0 |
|
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] |
1.0 |
|
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. |
1.0 |
|
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation |
0.99 |
|
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) |
0.99 |
|
Identification of long noncoding RNAs in T-ALL cell lines |
0.98 |
|
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia |
0.98 |
|
Gene expression profile of multiple myeloma cell lines treated with CB-5083 |
0.97 |
|
Effect of ILF3 depletion in HeLa cells on RNA steady state levels |
0.95 |
|
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ |
0.95 |
|
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations |
0.91 |
|
EWSR1 influences alternative splicing through direct and indirect mechanisms |
0.9 |
|
Transcriptome-wide identification of CELF2 functional targets in T cells |
0.86 |
|
circNFIB suppresses lymphatic metastasis of pancreatic cancer |
0.86 |
|
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] |
0.85 |
|
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course |
0.85 |
|
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains |
0.85 |
|
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells |
0.84 |
|
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] |
0.84 |
|
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy |
0.82 |
|
The Genetic Landscape of Diamond-Blackfan Anemia |
0.81 |
|
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) |
0.81 |
|
The expression profiles of GBC liver metastasis |
0.8 |
|
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity |
0.77 |
|
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex |
0.76 |
|
Oncogenic roles of ARID5B in T-ALL |
0.76 |
|
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) |
0.76 |
|
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line |
0.75 |
|
Expression profile of MM.1S tumors folloiwing treatment with bortezomib |
0.74 |
|
naive T cell heterogeneity after neonatal thymectomy |
0.74 |
|
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas |
0.73 |
|
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] |
0.73 |
|
Total RNA-Seq data from leukemic patients with complex structural variants |
0.72 |
|
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells |
0.71 |
|
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs |
0.69 |
|
LncRNA expression profiling of ischemic stroke patients |
0.69 |
|
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown |
0.69 |
|
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 |
0.69 |
|
Global response to chemotherapy-induced apoptosis |
0.67 |
|
Single-Cell Genotyping of Transcriptomes |
0.66 |
|
RNA-seq of Single-Cell Genotyping of Transcriptomes |
0.66 |
|
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) |
0.66 |
|
Frailty in middle age is associated with race-specific changes to the transcriptome. |
0.66 |
|
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire |
0.64 |
|
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] |
0.61 |
|
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] |
0.55 |
|
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation |
0.54 |
|
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] |
0.53 |
|
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. |
0.53 |
|
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication |
0.52 |
|
Genome-wide analysis of the Integrator complex (HTS) |
0.5 |
|
Genome-wide analysis of the Integrator complex |
0.5 |
|
Leucegene: AML sequencing (part 6) |
0.49 |
|
CD74 role in transcription regulation |
0.45 |
|
CD74 role in transcription regulation [RNA-seq] |
0.45 |
|
Regulating Interleukin-2 activity with engineered receptor signaling clamps |
0.44 |
|
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome |
0.44 |
|
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. |
0.42 |
|
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome |
0.41 |
|
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii |
0.39 |
|
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants |
0.35 |
|
RNA-Seq of PRMT1 overexpression ECA109 cells |
0.35 |
|
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics |
0.32 |
|
Regulation of poly(A) tail and translation during the somatic cell cycle |
0.32 |
|
JAK dependent survival of ALK- ALCL |
0.3 |
|
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine |
0.3 |
|
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) |
0.29 |
|
Proliferation-correlated expression |
0.26 |
|
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways |
0.26 |
|
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs |
0.26 |
|
Impact on erythroid progenitor type on erythroid differntiation |
0.23 |
|
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] |
0.23 |
|
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients |
0.23 |
|
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells |
0.23 |
|
RNA-seq of CD33 KO and control HSPCs |
0.19 |
|
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities |
0.18 |
|
Transcriptional profile in human S. haematobium infection |
0.16 |
|
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells |
0.16 |
|
CD86 regulates a pro-survival signal in myeloma cells |
0.15 |
|
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming |
0.15 |
|
Enhancer activation during EGF response |
0.14 |
|
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells |
0.13 |
|
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis |
0.13 |
|
CDK4/6 inhibitor resistance in prostate cancer |
0.13 |
|
Downregulation of LATS kinases alters p53 to promote cell migration |
0.11 |
|
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants |
0.08 |
|
Transcriptome-wide modulation of splicing by the exon junction complex |
0.05 |
|
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 |
0.05 |
|
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing |
0.05 |
|
Expression analysis of the TAF1 syndrome |
0.05 |
|
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) |
0.04 |
|
Transcriptome analysis of diverse cell types infected with human cytomegalovirus |
0.04 |
|
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles |
0.02 |
|
single cell RNA-seq from Purkinje cell (ENCSR888LYA) |
0.02 |
|
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose |
0.01 |
|
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence |
0.01 |
|
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] |
0.0 |
|
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles |
0.0 |